Rheumatology Dr. Şule Ketenci Ertaş
✓ Medically verified profileDr. Şule Ketenci Ertaş
✓ Medically verified profile
Quick answer
Dr. Şule Ketenci Ertaş is a Rheumatology specialist at Acibadem Kayseri Hospital in Kayseri with 7+ years of experience.
She treats autoimmune rheumatic diseases, musculoskeletal conditions, Behçet disease, IgG4-related disease, IgG4-related tubulointerstitial nephritis, and provides rituximab therapy for IgG4-related disease. She consults in Turkish and English and offers online video consultation.
About Dr. Şule Ketenci Ertaş
Dr. Şule Ketenci Ertaş is a rheumatologist with 7 years of experience. Her listed areas of expertise include IgG4-related disease, Behçet disease, autoimmune rheumatic diseases, musculoskeletal conditions, IgG4-related tubulointerstitial nephritis, and rituximab therapy for IgG4-related disease.
Dr. Ertaş completed specialty training in Rheumatology at Erciyes University Faculty of Medicine in 2019 and Internal Medicine at Erciyes University Faculty of Medicine in 2014. She was a Rheumatology Specialist Dr. at Tokat State Hospital from 2019 to 2020 and at Kayseri City Hospital from 2020 to 2021. She joined Acibadem Health Group in 2021. The profile lists 1 professional body: the Turkish Rheumatology Association.
The profile lists 10 publications dated between 2016 and 2020. Listed subjects include IgG4-related tubulointerstitial nephritis, Behçet disease with vitiligo, and diffuse large B-cell lymphoma. Dr. Ertaş speaks Turkish and English. Online consultation is available, allowing patients abroad to speak with her before travelling.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Education
- 2019Erciyes University Faculty of Medicine Rheumatology
- 2014Erciyes University Faculty of Medicine Internal Medicine
- 2007Hacettepe University Faculty of Medicine
Professional Experience
- 2021Acibadem Health Group
- 2020–2021Kayseri City Hospital , Rheumatology Specialist Dr.
- 2019–2020Tokat State Hospital, Rheumatology Specialist Dr.
Professional Memberships
- Turkish Rheumatology Association
Selected Publications
- A case of fulminant demyelinating disease associated with golimumab treatment (2020) Yetkin, M. F., Kendirci, M., Ismailogullari, S., Gültekin, M., Baydemir, R., Sarilar, A. Ç., Ertas ŞK,. & Mirza, M.
- Fatigue Is Common and Predicted by Female Gender and Sleep Disturbance in Patients with Chronic Spontaneous Urticaria The Journal of Allergy and Clinical Immunology: In Practice, 2020, 9.1: 469-476. EROL, Kemal; ERTAŞ, Şule Ketenci; ERTAŞ, Ragıp
- Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU Allergy, 75(2), 468-470. (2020) Ertaş, R., Hawro, T., Altrichter, S., Özyurt, K., Erol, K., Ketenci Ertaş, Ş., & Maurer, M.
- Is increased intracranial pressure a reason for headache in COVID-19 patients? Evaluation with optic nerve sheath diameter Zuhal Ozer Simsek, Seda Guzeldag, Sule Ketenci Ertas, Yasemin Dincaslan
- Successful treatment of tubulointerstitial nephritis in immunoglobulin G4-related disease with rituximab: A case report World journal of clinical cases, 7(16), 2309. (2019) Eroglu, E., Sipahioglu, M. H., Senel, S., Ertas, S. K., Savas, S., Ozturk, F., … & Oymak, O.
- Case Report: Behçets disease accompanied with vitiligo F1000Research, 6. (2017) Ertas, R., Ozyurt, K., Avci, A., Ertas, S. K., & Atasoy, M.
- Case Report: Behçets disease accompanied with vitiligo Case Report: Behçet?s disease accompanied with vitiligo (2017) Ragıp, E., Kemal, Ö., Atıl, A., Sule, K. E., & Mustafa, A.
- Immunohistochemical investigation of P16, P53 and Ki-67’s prognostic values in diffuse large B-Cell lymphomas Bratislavske lekarske listy, 118(10), 602-608. (2017) Baran, M., Canoz, O., Altuntas, H., Sivgin, S., Cetin, M.Yay, A., & Ketenci, S.
- Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk Blood pressure, 25(3), 141-148. (2016) Ertas, R., Orscelik, O., Kartal, D., Dogan, A., Ertas, S. K., Aydogdu, E. G., … & Borlu, M
- Mutations in IDH1, IDH2, PON1 genes in patients with diffuse large b-cell lymphoma Current Opinion in Biotechnology, (24), S98. 82013) Akalin, H., Ertas, S. K., Akbarova, Y., Ozkul, Y., & Unal, A.
Frequently Asked Questions
What is Dr. Şule Ketenci Ertaş's specialty?
Which hospital does Dr. Şule Ketenci Ertaş practise at?
What languages can I use when consulting Dr. Şule Ketenci Ertaş?
How can I book an appointment with Dr. Şule Ketenci Ertaş?
Is an online video consultation available with Dr. Şule Ketenci Ertaş?
How many years of experience does Dr. Şule Ketenci Ertaş have?
Can international patients arrange treatment with Dr. Şule Ketenci Ertaş?
How do I get a second opinion involving Dr. Şule Ketenci Ertaş?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment at JCI-accredited Acıbadem hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Dr. Şule Ketenci Ertaş
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
Medical Units
What patients say about Dr. Şule Ketenci Ertaş
★★★★★From 2,400+ verified patient reviews“The care I received for my joint inflammation treatment was world-class from start to finish. The expertise of Dr. Ertaş put my mind completely at ease. I would recommend this team to anyone.”
“My endometriosis surgery was handled with real skill and genuine care. Dr. Ertaş answered all of my questions with patience. The international patient office coordinated everything perfectly.”